Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Allergen-specific IgG antibody production refers to the generation of immunoglobulin G (IgG) antibodies that specifically recognize and bind to allergens. This process is a key component of the immune response, particularly in the context of allergen exposure and allergen immunotherapy (AIT). Allergen-specific IgGs, especially IgG4, play a central role in regulating secondary immune responses after exposure or therapy. They act mainly by competing with pathogenic IgEs, thus inhibiting downstream allergic inflammation. Their measurement serves both diagnostic and therapeutic monitoring purposes.
Competes with IgE for allergen binding, prevents mast cell and basophil activation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Allergen-specific IgG Antibody Production.